Biotinidase deficiency: Genotype-biochemical phenotype association in Brazilian patientsReport as inadecuate




Biotinidase deficiency: Genotype-biochemical phenotype association in Brazilian patients - Download this document for free, or read online. Document in PDF available to download.

Introduction

The association between the BTD genotype and biochemical phenotype profound biotinidase deficiency BD, partial BD or heterozygous activity is not always consistent. This study aimed to investigate the genotype-biochemical phenotype association in patients with low biotinidase activity.

Methods

All exons, the 5-UTR and the promoter of the BTD gene were sequenced in 72 Brazilian individuals who exhibited low biotinidase activity. For each patient, the expected biochemical phenotype based on the known genotype was compared with the observed biochemical phenotype. Additional non-genetic factors that could affect the biotinidase activity were also analysed.

Results

Most individuals were identified by neonatal screening n = 66-72. When consecutive results for the same patient were compared, age, prematurity and neonatal jaundice appeared to affect the level of biotinidase activity. The biochemical phenotype at the time of the second blood collection changed in 11-22 patients compared to results from the first sample. Three novel variants were found: c.1337T>C p.L446P, c.1466A>G p.N489S and c.962G>A p.W321*. Some patients with the same genotype presented different biochemical phenotypes. The expected and observed biochemical phenotypes agreed in 68.5% of cases concordant patients. The non-coding variants c.-183G>A, c.-315A>G and c.-514C>T were present in heterozygosis in 5-17 discordant patients. In addition, c.-183G>A and c.-514C>T were also present in 10-37 concordant patients.

Conclusions

The variants found in the promoter region do not appear to have a strong impact on biotinidase activity. Since there is a disparity between the BTD genotype and biochemical phenotype, and biotinidase activity may be affected by both genetic and non-genetic factors, we suggest that the diagnosis of BD should be based on more than one measurement of plasma biotinidase activity. DNA analysis can be of additional relevance to differentiate between partial BD and heterozygosity.



Author: Taciane Borsatto , Fernanda Sperb-Ludwig, Samyra E. Lima, Maria R. S. Carvalho, Pablo A. S. Fonseca, José S. Camelo Jr, Erlane M

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents